| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/23/2011 | CN101168041B Rheumatism treating medicine |
| 03/23/2011 | CN101168008B Medicinal composition with tumor inhibition function and preparation method and application thereof |
| 03/23/2011 | CN101161280B Medicine for curing epilepsy |
| 03/23/2011 | CN101156934B Spray for treating burn |
| 03/23/2011 | CN101152149B Trigone-leaf dioscorea opposita saponin liposome, method for preparing the same and use of the same |
| 03/23/2011 | CN101129467B Traditional Chinese medicine for treating paraplegia |
| 03/23/2011 | CN101129449B Chinese medicine for treating immune infertility and method of preparing the same |
| 03/23/2011 | CN101084882B Polyalkylcyanoacrylate nano-capsule and preparation method and application thereof |
| 03/23/2011 | CN101062348B Ganoerma lucidum capusule for reducing blood sugar |
| 03/22/2011 | USRE42243 Synthetic viscoelastic material for ophthalmic applications |
| 03/22/2011 | US7910791 Combination SIS and vacuum bandage and method |
| 03/22/2011 | US7910641 PH modulated films for delivery of actives |
| 03/22/2011 | US7910589 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/22/2011 | US7910554 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer |
| 03/22/2011 | US7910204 Antimicrobial composites, films, labelstocks and labels |
| 03/22/2011 | US7910151 Cap openings in reservoirs electrically conductive; connect titanium, platinum, gold cap with electrical lead; current supply and distributor selectively passes current through each cap; sensor component for detection of glucose, urea; drug release system; implantable catheter |
| 03/22/2011 | US7910140 Heating plant extracts such as lupulone and propylene glycol, then adding group IA hydroxides and cooling to form solutions used as bactericides or microbiocides; biological antigrowth agents |
| 03/22/2011 | US7910137 Metal carnitine chelates |
| 03/22/2011 | US7910135 Hydrogel wound dressing and biomaterials formed in situ and their uses |
| 03/22/2011 | US7910134 Alloplastic injectable dermal filler and methods of use thereof |
| 03/22/2011 | US7910133 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 03/22/2011 | US7910132 Pharmaceutical composition for the treatment of acute disorders |
| 03/22/2011 | US7910131 Method of treating seizures using modified release formulations of oxcarbazepine |
| 03/22/2011 | US7910128 sustained release profile at lower pH and an accelerated dissolution profile at higher pH; improved bioavailability |
| 03/22/2011 | US7910126 Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same |
| 03/22/2011 | US7910124 Load bearing biocompatible device |
| 03/22/2011 | US7910121 Soluble cosmetic article with a thermal effect |
| 03/22/2011 | US7910120 Adhesive block ethylenic copolymers, cosmetic compositions containing them and cosmetic use of these copolymers |
| 03/22/2011 | US7910114 Methods of treating infectious diseases |
| 03/22/2011 | US7910086 Nanoparticles for protein drug delivery |
| 03/22/2011 | US7910031 Process for forming an ingestible thin film with non-self-aggregating uniform heterogeneity |
| 03/22/2011 | CA2553381C Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| 03/22/2011 | CA2484275C Warming and nonirritating lubricant compositions and method of comparing irritation |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2473885C Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias |
| 03/22/2011 | CA2471769C Oral insulin therapy |
| 03/22/2011 | CA2471543C Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 03/22/2011 | CA2464735C An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 03/22/2011 | CA2464067C Method for treating non-neuropathic pain |
| 03/22/2011 | CA2455939C Sucralose formulations to mask unpleasant tastes |
| 03/22/2011 | CA2452330C Controlled agglomeration |
| 03/22/2011 | CA2442960C Vessel sealing instrument |
| 03/22/2011 | CA2406201C Improvements in or relating to formulations for use in inhaler devices |
| 03/22/2011 | CA2397294C Glyburide composition |
| 03/22/2011 | CA2386027C Biodegradable carrier systems for therapeutically active substances and process for their production |
| 03/22/2011 | CA2379357C Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 03/22/2011 | CA2359334C Bifidobacterium in the treatment of inflammatory disease |
| 03/22/2011 | CA2317921C Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 03/22/2011 | CA2304808C Liquid interferon-.beta. formulations |
| 03/17/2011 | WO2011032126A1 Protein imprinting by means of alginate-based polymer microcapsules |
| 03/17/2011 | WO2011031996A2 Engineered microparticles for macromolecule delivery |
| 03/17/2011 | WO2011031855A2 Implantable device for controlled drug delivery |
| 03/17/2011 | WO2011031849A2 Anionic lipids and lipid nanostructures and methods of producing and using same |
| 03/17/2011 | WO2011031819A2 Break resistant gel capsule |
| 03/17/2011 | WO2011031771A1 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| 03/17/2011 | WO2011031621A2 High strength seamless alginate capsules |
| 03/17/2011 | WO2011031617A2 Seamless alginate capsules |
| 03/17/2011 | WO2011031564A2 Methods and systems for dosing and coating inhalation powders onto carrier particles |
| 03/17/2011 | WO2011031561A2 Nucleic acid molecules and uses thereof |
| 03/17/2011 | WO2011031553A2 Implantable device for production of interleukin-1 receptor antagonist |
| 03/17/2011 | WO2011031524A2 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 03/17/2011 | WO2011031476A2 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation |
| 03/17/2011 | WO2011031462A2 Compositions for delivery of insoluble agents |
| 03/17/2011 | WO2011031301A2 Intrapericardial delivery of periostin |
| 03/17/2011 | WO2011031284A1 Polymeric carrier compositions for the delivery of active agents, methods of making and using the same |
| 03/17/2011 | WO2011031176A1 Oral suspension formulations of esclicarbazepine acetate |
| 03/17/2011 | WO2011031116A2 Pad for herbal medicine in which release of medicinal ingredient can be controlled, and manufacturing method thereof |
| 03/17/2011 | WO2011031018A2 Water-soluble drug delivery system allowing slow release |
| 03/17/2011 | WO2011030659A1 Antacid and laxative tablet |
| 03/17/2011 | WO2011030343A1 Devices, systems and methods for adjusting fluid delivery parameters |
| 03/17/2011 | WO2011030166A1 The use of lipid emulsions for binding hepatitus c virus |
| 03/17/2011 | WO2011029948A2 Transdermal therapeutic system for administering fentanyl or an analogue thereof |
| 03/17/2011 | WO2011029942A1 Compositions containing coenzyme q-10 and an antioxidant |
| 03/17/2011 | WO2011029909A1 Solid dispersion comprising an anti-hiv agent |
| 03/17/2011 | WO2011029868A1 Pharmaceutical formulation containing ribavirin |
| 03/17/2011 | WO2011029598A1 Transdermal patch formulation |
| 03/17/2011 | WO2011029218A1 Use of montmorillonite in manufacture of medicaments |
| 03/17/2011 | WO2011029208A1 Device to be implanted in a human or animal body for material or signal delivery or acquisition within the body |
| 03/17/2011 | WO2011029181A1 Choline fenofibrate delayed release compositions |
| 03/17/2011 | WO2011011631A3 Nucleic acid delivery vehicles |
| 03/17/2011 | WO2011004126A4 Substrate impregnated with sprayed clay, and method for manufacturing same |
| 03/17/2011 | WO2011002953A3 Topical skin treatment kits |
| 03/17/2011 | WO2010143827A3 Oil-gel soft patch for attachment to the skin and method for preparing same |
| 03/17/2011 | WO2010133211A4 Decolorized extracts of the plant pandanus conoideus |
| 03/17/2011 | WO2010132331A3 Ingestible event markers comprising an ingestible component |
| 03/17/2011 | WO2010131909A3 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases |
| 03/17/2011 | WO2010123563A3 Controlled release dispensing device |
| 03/17/2011 | WO2010118435A3 Par-1 activation by metalloproteinase-1 (mmp-1) |
| 03/17/2011 | WO2010111215A4 Compositions and methods for treatment of hemorrhage |
| 03/17/2011 | WO2010066687A3 Stabalized statin-comprising compositions |
| 03/17/2011 | WO2010057449A3 A solid pharmaceutical composition with atorvastatin and telmisartan as the active substances |
| 03/17/2011 | WO2010019279A8 Pharmaceutical compositions configured to deter dosage form splitting |
| 03/17/2011 | WO2009135646A3 Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110066228 Carrier and kit for intraluminal delivery of active principles or agents |
| 03/17/2011 | US20110066182 Tissue Sealant for Use in Non Compressible Hemorrhage |
| 03/17/2011 | US20110066141 Implantable medical device having an anti-gastric distress agent |
| 03/17/2011 | US20110066135 Sinus delivery of sustained release therapeutics |
| 03/17/2011 | US20110066130 Abuse Potential Reduction in Abusable Substance Dosage Form |
| 03/17/2011 | US20110066101 Non-invasive ocular drug delivery |